
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT's weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. A reminder that if you're ever feeling down about a mistake you made, there is always a way to turn it around -- like how this delivery robot company has turned the issue of its robot crashing into my local bus stop into a marketing opportunity.
After Bain Capital last summer said it licensed five immunology drugs from Bristol Myers Squibb, it's now unveiling the company to take those treatments forward: a startup called Beeline Medicines.